Compare ANIX & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIX | VIRC |
|---|---|---|
| Founded | 1982 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.5M | 99.1M |
| IPO Year | 2013 | 1995 |
| Metric | ANIX | VIRC |
|---|---|---|
| Price | $3.39 | $6.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.67 | $7.30 |
| AVG Volume (30 Days) | ★ 282.9K | 111.8K |
| Earning Date | 05-27-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | ★ 12.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $199,652,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.32 | $5.16 |
| 52 Week High | $5.46 | $9.07 |
| Indicator | ANIX | VIRC |
|---|---|---|
| Relative Strength Index (RSI) | 62.87 | 48.00 |
| Support Level | $2.90 | $5.99 |
| Resistance Level | $3.53 | $6.47 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 79.92 | 17.68 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.